Target intelligence / Profile preview

Cellular lipid pools and biological membranes

Molecular classification
Other, Lipid, Cellular Component
01

Overview

Biological membranes and cellular lipid pools are fundamental structural components that define the boundaries of cells and organelles, providing a semi-permeable barrier and a platform for biochemical signaling (Nature Reviews Molecular Cell Biology, 2006). They consist primarily of phospholipids, sterols, and sphingolipids organized into bilayers that maintain cellular homeostasis and compartmentalization (Wikipedia, "Cell membrane"). In pharmacology, these structures are targeted by various anti-infective agents that exploit differences between host and pathogen lipid compositions, such as polyene antifungals like Amphotericin B which bind to ergosterol (PubChem, CID 5280965). Similarly, lipopeptide antibiotics like Daptomycin insert into bacterial membranes to cause rapid depolarization and cell death (NCBI, PMC4159391). Beyond infections, alterations in lipid pool dynamics and membrane fluidity are implicated in the pathogenesis of metabolic syndromes, neurodegenerative diseases, and cancer (Journal of Lipid Research, 2012). Therapeutic strategies targeting these components often face challenges regarding selectivity to avoid systemic toxicity and hemolysis in the host (StatPearls, "Polymyxin B"). These targets are unique because they are often addressed through physical-chemical interactions rather than specific lock-and-key protein binding. Overall, they represent a broad but vital class of non-proteinaceous therapeutic targets in modern medicine.

Other names
Cell membranePlasma membraneLipid bilayerCytoplasmic membraneIntracellular lipid dropletsBiological membraneLipid rafts
02

Mechanism of action

Direct disruption of the lipid bilayer, formation of transmembrane pores, or sequestration of specific lipid species to alter membrane permeability and signaling.

03

Biological functions

Signal transductionCompartmentalizationPermeability barrierCellular homeostasisOther
04

Disease associations

InfectionCancerNeurodegenerative diseaseMetabolic diseaseInflammationOther
05

Safety considerations

Non-specific toxicityHemolysisNephrotoxicityPotential for off-target effects on host cell membranes
06

Interacting drugs

Amphotericin B

6 more in the full profile.

07

Biomarkers

Membrane potentialLipidomic profileLactate dehydrogenase (LDH) release

Beyond the preview

Go deeper on Cellular lipid pools and biological membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular lipid pools and biological membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call